The Responsibility of Clinical Pharmacists for the Safety of Medication Use in Hospitalized Children: A Middle Eastern Experience

سال انتشار: 1398
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 330

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

AECPMED02_057

تاریخ نمایه سازی: 28 بهمن 1398

چکیده مقاله:

We aimed to detect and report the frequency of occurrence of drug-related problems (DRPs) in a Middle Eastern University Children’s Hospital (Isfahan, Iran) and classify them in terms of their nature and cause to clarify the responsibility of clinical pharmacists for the safe utilization ofmedications in hospitalized children. Methods: In this cross-sectional study which was carried out in Imam Hossein Children’s University Hospital affiliated with Isfahan University of Medical Sciences (Isfahan, Iran) from September 2017 to May 2018, DRPs during the hospitalization of pediatric patients in three medical wards, the pediatric intensive care unit, and two neonatal intensive care units were detected and identified concurrently with the treatment process using Pharmaceutical Care Network of Europe data gathering form for DRPs v. 8.01. All cases were verified and validated in a professional focus group before documentation. Findings: We detected 427 DRPs in 201 out of 250 randomly includedhospitalized children in which 86% of them were directly reported by the hospital’s clinical pharmacist. The highest frequency of DRPs (47.3%) was observed in the age range of 1 month–2 years. Safety of treatment was the most frequently reported as the nature of the problem (43.5%), followed by effectiveness issues (36.8%). The most frequent cause of DRPs was dose selection issues (34.2%), followed by drug-type selection (25.5%), and unavailability of appropriate dosage forms (13.6%). Ninetyeight interventions were proposed by the clinical pharmacist, in which 59.2% of them were accepted. Conclusion: This study confirms the necessity for the active role of clinical pharmacists before, during,and after drug therapy in hospitalized pediatric patients for the safety and proper utilization of drugs in this vulnerable population.

نویسندگان

Khatereh Jafarian

Pharmacy Students’ Research Committee,Isfahan University of Medical Sciences, Isfahan, Iran

Zahra Allameh

Department of Pharmaceutical Care, Imam Hossein Children’s Hospital, Isfahan University of Medical Sciences, Isfahan, Iran

Mehrdad Memarzadeh

Department of Pediatric Surgery, Imam Hossein Children’s Hospital, Isfahan University of Medical Sciences, Isfahan, Iran

Ali Saffaei

Department of Clinical Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Payam Peymani

Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran

Ali Mohammad Sabzghabaee

Isfahan Clinical Toxicology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran